Parikh Anand Kiran has filed 4 insider transactions across 1 company since February 2026.
Most recent transaction: a grant/award of 809822 shares of Sensei Biotherapeutics, Inc. ($SNSE) on February 17, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2026 | Sensei Biotherapeutics, Inc. | $SNSE | Parikh Anand Kiran | Chief Operating Officer | A | Series B Preferred Stock | 809822 | $0.00 | 809,822.0000 | 1,261,290 | 9999.99% | 64.21% |
| Feb. 17, 2026 | Sensei Biotherapeutics, Inc. | $SNSE | Parikh Anand Kiran | Chief Operating Officer | A | Employee Stock Option (right to buy) | 92533 | $0.00 | 92,533.0000 | 1,261,290 | 9999.99% | 7.34% |
| Feb. 17, 2026 | Sensei Biotherapeutics, Inc. | $SNSE | Parikh Anand Kiran | Chief Operating Officer | A | Employee Stock Option (right to buy) | 56673 | $0.00 | 56,673.0000 | 1,261,290 | 9999.99% | 4.49% |
| Feb. 19, 2026 | Sensei Biotherapeutics, Inc. | $SNSE | Parikh Anand Kiran | Chief Operating Officer | A | Employee Stock Option (right to buy) | 1239305 | $0.00 | 1,239,305.0000 | 1,261,290 | 9999.99% | 98.26% |